www.tickerreport.com ·
North Dakota State Investment Board Makes New 2 69 Million Investment in Incyte Corporation Incy
Topic context
This topic has been covered 404610 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThe news reports institutional investment activity in Incyte Corporation, a biopharmaceutical company. The commercial mechanism is weak: it reflects portfolio allocation decisions by a state pension fund, not a change in Incyte's product pipeline, revenue drivers, or input costs. No direct impact on drug pricing, supply chain, or margins is indicated. The sector is PHARMA_BIOTECH but the signal is limited to equity demand.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- North Dakota State Investment Board invested $2.69 million in Incyte Corporation (NASDAQ: INCY) by acquiring 27,272 shares in Q4.
- Incyte reported Q4 EPS of $1.81, beating analysts' expectations.
- Incyte's quarterly revenue was $1.27 billion, a 20.9% increase year-over-year.
- Market cap of Incyte is $19.02 billion; 52-week stock range $62.84-$112.29.
- Other institutional investors (AustralianSuper, Rakuten) also increased stakes in Q3.
Related stories
finance.yahoo.com
Ncmi Q1 2026 Earnings Transcript
finance.yahoo.com
Transcript Valneva Q1 2026 Earnings
finance.yahoo.com
Aytu Aytu Q3 2026 Earnings
fool.com
Keysight Keys Q2 2026 Earnings Transcript
economictimes.indiatimes.com